Jim Cramer, Fed and tech stocks
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
Jim Cramer said during his latest program on CNBC that the Federal Reserve wanted to contain inflation and make sure it’s ...
CNBC’s Jim Cramer said the Fed’s successful start to the easing cycle is leading the market in a positive direction.
Stocks to Watch in September. Since Southern Co (NYSE:SO) ranks 7th on the list, it deserves a deeper look. Jim Cramer said ...